Term Name: | alpha-NeuGc-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer |
---|---|
Synonyms: | (2S,3R,4E)-2-acylamino-3-hydroxyoctadec-4-en-1-yl 3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-bet, alpha-NeupGc-(2->3)-beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer, IV(3)NeuGcalpha-Gg4Cer, N-glycoloyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide, NeuGcalpha2-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glc-Cer, NeuGcalpha2->3Galbeta1->3GalNAcbeta1->4Galbeta1->4Glc-Cer |
Definition: | A sialotetraosylceramide consisting of a linear pentasaccharide made up from a sialyl residue, two galactose residues, one N-acetylglucosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a beta-linkage. |
Ontology: | ChEBI [CHEBI:142419] ( EBI ) |